Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
Clinical trial NCT03979131 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03979131
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2023-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.